Latest therapeutics News | Page 16

Manchester academics selected in Top 50 Women in Engineering
NSW & QLD Government investments into industry welcomed
New orphan drug designation for Kazia Therapeutics’ paxalisib
More than one way to skin tumor
New agreement under C-TAP aims to improve global access to Covid testing technologies
NeuroScientific Biopharmaceuticals reports positive data from animal study
RNA boost for autoimmune disease
Innovative mRNA research project to tackle cardiovascular disease
Australian invention enables post-partum depression medication to be administered as simple oral capsule
Sepsis research accelerated by James N. Kirby Foundation Grant
Monash mRNA projects get funding boost
New projects announced for National Drug Discovery Centre
WHO teams up with world’s leading organization for physicians and oncology professionals
WHO consultations sets research priorities for monkeypox
Cornellian-founded company implants 3D-bioprinted ear
Rapid lab analysis informs global guidelines on Covid vaccination and treatment
Cynata Therapeutics adds new site for MEND clinical trial
PM’s Science Prize for preventing brain damage in newborns
Very high doses of cannabis component CBD don’t affect driving
Profile successes and add your voice
Researcher focuses on essential, but often-ignored, organ in pregnancy
Brisbane scientists awarded US funding to help fight new viruses like COVID & Monkeypox
Charles Sturt University receives Regional Research Collaboration funding
Early detection of Alzheimer’s possible – research
On trail of urinary tract infections
Burnet Institute partners with Moderna to develop novel mRNA vaccines
Genetic study identifies migraine causes and promising therapeutic targets
Tumor release of lactate forces nearby cells into supportive role
Prescient expands PTX-200 AML cohort following additional complete remission
T cell behavior determines immunotherapy success
Filling gaps in immune system cancer research
New senior appointments for Tessara Therapeutics
Leveraging science of hibernation to improve human heart health
$10 million investment fuels promising treatments for inflammatory lung disease
Researcher founding scientist of new biotech company launched with AUD$10m investment
Entrepreneurs compete for better future at Tech Tournament
Findings open way for personalised MS treatment
Lupus-causing gene paves way for new and tailored treatments
Scientists prove diseased blood vessels communicate with brain
‘Very optimistic’: Research offers hope for MND and Alzheimer’s gene treatment
New UK-based business development for Adherium
NSW Government seeks operator for RNA manufacturing
AMS Book adds new chapter – Antimicrobial stewardship in dental practice
Zelria Therapeutics executes acquisition of Health House
EpiAxis Therapeutics appoints new chief science officer
Invest more to cut bowel disorder hospital cases
Statement on eleventh meeting of International Health Regulations Emergency Committee regarding coronavirus disease pandemic
Brendan Crabb: Australia’s $85 million commitment to COVAX welcomed